Klinic prescribes four FDA-approved, branded weight loss medications: Wegovy (a once-weekly semaglutide injection), Oral Wegovy (a daily semaglutide pill), Zepbound (a once-weekly tirzepatide injection that targets both GLP-1 and GIP), and Foundayo (a once-daily orforglipron pill that can be taken at any time with no food or water restrictions)
This diagnostic use is less common today, but may be seen in specialized testing
Pannacciulli N, Bunt JC, Koska J, Bogardus C, Krakoff J: Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans
The incretin effect was estimated to account for approximately 50% - 70% of the postprandial insulin responses in healthy individuals and may be substantially reduced to 20% 30% in individuals with type 2 diabetes mellitus (T2DM) (6, 7), a complex disorder arising from inadequate compensation of insulin secretion by pancreas to counter peripheral insulin resistance